Qiagen
QGEN
#1942
Rank
C$13.76 B
Marketcap
C$63.49
Share price
-2.45%
Change (1 day)
1.79%
Change (1 year)

P/E ratio for Qiagen (QGEN)

P/E ratio as of December 2025 (TTM): 24.5

According to Qiagen 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.5414. At the end of 2024 the company had a P/E ratio of 113.

P/E ratio history for Qiagen from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024113308.14%
202327.79.86%
202225.38.8%
202123.2-26.91%
202031.8-118.28%
2019-174-551.21%
201838.5-76.83%
2017166120.15%
201675.565.77%
201545.57.74%
201442.3-41.6%
201372.4140.06%
201230.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Thermo Fisher Scientific
TMO
32.8 33.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
29.9 22.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
34.0 38.63%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
38.0 54.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
121 391.33%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.